- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
India Glycols Limited (IGL) is undergoing a significant transformation post-demerger, now sharply focused on sustainable specialty chemicals. The demerger became effective on September 1, 2026, creating three independent entities for improved focus and capital allocation.
**Business Performance:** For the retained IGL business, FY26 net sales were ₹1,164 Cr. While revenue moderated due to discontinuation of less profitable operations, Adjusted EBITDA soared to ₹330 Cr (28.4% margin) in FY26, up from ₹247 Cr (15.6%) in FY24, showing strong profitability improvement. Key revenue drivers include Bio-Glycols, Glycol Ethers, and the Clariant JV.
**Growth & Outlook:** IGL has a bold 10-year vision for 10x sales and profit growth, aspiring for ₹2,000 Cr net revenue and ₹400 Cr EBITDA within 4-5 years. The strategy centers on scaling sustainable specialty materials, performance chemicals, and exploring novel technologies like CCUS. The company aims to accelerate growth via differentiated products, global market expansion, and capitalizing on the shift towards sustainable sourcing, leveraging its unique bio-based chemistry platform.